Scheme Profile

Mirae Asset Healthcare Fund - Regular (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
2,908
Inception Date
02-07-2018
Category
Equity - Sectoral - Pharma

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 5000
  • 52 Week High / Low ()
  • 40.128 (29-Jul-2025) / 33.485 (28-Feb-2025)
  • Incremental Investment ()
  • 1000
  • NAV ()
  • 38.11 ( -0.06) ( -0.15 %)
  • Benchmark
  • BSE Healthcare TRI
  • Fund Manager
  • Vrijesh Kasera
  • Value of () 1,00,000 since inception
  • 3,81,080
  • Entry Load
  • NIL
  • Exit Load
  • 15% of the units allotted (including Switch-in/STP - in on or before completion of 365 days from the date of allotment of units: Nil. 1.00% - If redeemed within 1 year (365 days) from the date of allotment. Nil - If redeemed after 1 Year (365 days) from the date of allotment.
  • Expense Ratio (%)
  • 1.92
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 59.35 times
  • Portfolio P/B
  • 7.84 times
  • Average Maturity
  • -
  • Yield To Maturity
  • -
  • Modified Duration
  • -
  • Turnover Ratio (%)
  • 0.38

Risk Factors

  • Jenson's Alpha
  • 11.37
  • Standard Deviation
  • 4.62
  • Beta
  • 0.77
  • Sharpe
  • 1.03
  • R-Squared
  • 1.00
  • Treynor Factor
  • 0.04

NAV Movement

AUM Growth ( Cr.)

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • BSE Healthcare TRI
  • 10.35
  • -0.51
  • 15.09
  • 48.32
  • 13.19
  • 22.14
  • 13.77
  • -

Company Top 5 Holdings

  [ As on 31 Jul 2025 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Sun Pharmaceutical Industries Ltd
  • Equity
  • 18,29,418
  • 10.74
  • Divis Laboratories Ltd
  • Equity
  • 3,53,681
  • 8.02
  • Glenmark Pharmaceuticals Ltd
  • Equity
  • 9,86,043
  • 7.24
  • Aurobindo Pharma Ltd
  • Equity
  • 16,36,058
  • 6.41
  • Cipla Ltd
  • Equity
  • 11,43,081
  • 6.11

Sector Top 5 Holdings

  [ As on 31 Jul 2025 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 1,45,11,970
  • 80.28
  • Healthcare
  • 49,83,649
  • 17.54
  • Chemicals
  • 2,27,131
  • 1.34
  • IT - Software
  • 52,59,520
  • 0.85

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD -4.01 -4.24 - 1.66 2,908.21
2024 38.73 34.92 10.35 8.12 2,863.52
2023 34.45 31.12 38.35 18.10 2,035.25
2022 -11.94 -9.58 -11.31 2.80 1,631.86
2021 25.76 17.96 20.57 21.69 1,935.10
2020 73.37 65.84 62.19 15.60 1,209.93
2019 6.24 4.22 -3.06 13.79 366.91
2018 2.65 -2.00 -5.45 6.67 314.94

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Jun-2025 6.62 7.66 - 0 2,785.12
Mar-2025 -8.04 -8.95 - 0 2,667.40
Dec-2024 1.13 1.62 - 0 2,863.52
Sep-2024 19.37 19.55 - 0 2,793.61

Peer Comparison

<< < 12> >> 

Asset Allocation

Sector Allocation

Close